TheProfitWatch

OCS - Oculis Holding AG Ordinary shares

Day 1m 10m 60m PreMarket Market AfterHours Gap
21.7 -0.36 (-1.66%) --- --- --- --- -0.36 (-1.66%) --- ---

Oculis Holding AG is a global biopharmaceutical company purposefully driven to save sight and improve eye care. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED); and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis.

Category: /stock/categories/na
Market Period: PreMarket

Earnings & Ratios

Basic EPS:
Diluted EPS:
Basic P/E:
Diluted P/E:
RSI(14) 1m:
78.57
VWAP:
21.31
RVol:

Events

Period Kind Movement Occurred At

Related News